International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-3
Original Research Article
ROLE OF MR SPECTROSCOPY IN EVALUATION OF INTRAAXIAL BRAIN TUMORS
Published
March 6, 2024
Abstract

AIMS AND OBJECTIVES: To determine biochemical markers of intraaxial brain tumors using MR spectroscopy.To evaluate role of MR spectroscopy in diagnosing and grading of intraaxial brain with histopathological correlation.To evaluate role of MR spectroscopy in determining the infiltrative nature of the intra axial brain tumor. MATERIALS AND METHODS: A total of 30 patients with intraaxial brain tumors referred to department of Radiodiagnosis were imaged with 1.5 Tesla MRI Scanner , Siemens magnetomavantoSyngo (MR D-13) 16 channel machine in the department of Radiodiagnosis.Its study of observation cross sectional study & a total of 30 patients fulfilling the selection criteria were studied. RESULTS: Out of 30 patients with intraaxial brain tumors 11 patients are diagnosed with GBM,2 with anaplastic astrocytoma,3 with diffuse infiltrative astrocytoma,2 with oligodendroma,2 with gliomatosis cerebri,2 with ependymoma,2 with mediulloblastoma,1 with metastasis,1 with choroid plexus papilloma and one with lymphoma. CONCLUSION: MR spectroscopy is a reliable method for glioma grading.It is useful in discrimination between WHO grade II and grade III ,IV astrocytomas as well as other intraaxial brain tumors.The spectroscopic MR measurements in the peritumoral region can be used to demonstrate differences in solitary metastases and high grade gliomas and also peritumoral infiltrative nature of certain intraaxial brain tumor.

Recommended Articles
Loading Image...
Volume-5, Issue-3
Citations
590 Views
433 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved